Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction

Kim Robin van Daalen1, Dudan Zhang1, Stephen Kaptoge1

  • 1British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.

PubMed

Insights

Cardiovascular disease risk scores help prevent heart disease deaths. This review guides selecting the best score for your population to ensure accurate risk assessment and informed clinical decisions.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Health Services Research

Background:

  • Cardiovascular diseases (CVDs) are the leading global cause of mortality.
  • Cardiovascular disease risk scores are crucial for primary prevention, identifying high-risk individuals for interventions.
  • Existing risk scores vary significantly due to differing data sources and populations, potentially leading to inaccurate risk assignments.

Purpose of the Study:

  • To provide an updated overview of guideline-recommended cardiovascular disease risk scores.
  • To evaluate and compare the characteristics and qualities of various risk scores.
  • To offer guidance on selecting the most appropriate risk score for specific target populations.

Main Methods:

  • Systematic review of guideline-recommended cardiovascular disease risk scores.
  • Comparative analysis of risk score derivation data, population applicability, and assigned risk values.
  • Evaluation of global, regional, and national risk scoring tools.

Main Results:

  • Significant heterogeneity exists among cardiovascular disease risk scores in terms of data sources and risk prediction accuracy.
  • Mismatches between derivation and target populations can lead to risk over/underestimation and suboptimal clinical decisions.
  • A wide array of risk scores necessitates careful selection based on population-specific epidemiology.

Conclusions:

  • Accurate cardiovascular disease risk assessment is vital for effective primary prevention.
  • Selection of an appropriate risk score requires careful consideration of its origin and applicability to the target population.
  • This review aims to facilitate informed choices among available cardiovascular disease risk scores to improve patient outcomes.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
309
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
142
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
120
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
72
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
539